| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 43 | 2023 | 627 | 9.710 |
Why?
|
| Early Detection of Cancer | 39 | 2023 | 529 | 7.980 |
Why?
|
| Hypertension | 31 | 2023 | 469 | 6.460 |
Why?
|
| Mass Screening | 29 | 2023 | 671 | 4.330 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 20 | 2023 | 53 | 4.270 |
Why?
|
| Occult Blood | 26 | 2020 | 155 | 4.190 |
Why?
|
| Telemedicine | 13 | 2022 | 182 | 2.750 |
Why?
|
| Postal Service | 15 | 2020 | 72 | 2.670 |
Why?
|
| Patient Compliance | 10 | 2017 | 278 | 2.630 |
Why?
|
| Antihypertensive Agents | 13 | 2022 | 155 | 2.470 |
Why?
|
| Feces | 10 | 2020 | 85 | 2.260 |
Why?
|
| Humans | 100 | 2023 | 17376 | 2.240 |
Why?
|
| Reminder Systems | 8 | 2020 | 74 | 2.180 |
Why?
|
| Colonoscopy | 16 | 2023 | 257 | 2.010 |
Why?
|
| Middle Aged | 57 | 2023 | 7885 | 1.980 |
Why?
|
| Blood Pressure | 14 | 2023 | 275 | 1.910 |
Why?
|
| Aged | 48 | 2023 | 6129 | 1.810 |
Why?
|
| Male | 57 | 2022 | 9843 | 1.750 |
Why?
|
| Electronic Health Records | 15 | 2020 | 707 | 1.730 |
Why?
|
| Female | 65 | 2023 | 12444 | 1.690 |
Why?
|
| Internet | 8 | 2014 | 212 | 1.630 |
Why?
|
| Patient-Centered Care | 5 | 2016 | 190 | 1.550 |
Why?
|
| Research Design | 8 | 2020 | 343 | 1.550 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 380 | 1.490 |
Why?
|
| Medicaid | 6 | 2020 | 184 | 1.470 |
Why?
|
| Motivation | 4 | 2021 | 116 | 1.460 |
Why?
|
| Primary Health Care | 11 | 2022 | 729 | 1.430 |
Why?
|
| Pharmacists | 11 | 2022 | 48 | 1.330 |
Why?
|
| Patient Selection | 5 | 2016 | 178 | 1.270 |
Why?
|
| Blood Pressure Determination | 8 | 2023 | 52 | 1.220 |
Why?
|
| Washington | 12 | 2021 | 385 | 1.090 |
Why?
|
| Colonic Neoplasms | 3 | 2020 | 163 | 1.060 |
Why?
|
| Medicare | 7 | 2023 | 201 | 1.050 |
Why?
|
| Patient Care Team | 5 | 2014 | 107 | 0.990 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2015 | 9 | 0.910 |
Why?
|
| Pharmaceutical Services | 4 | 2013 | 34 | 0.890 |
Why?
|
| Follow-Up Studies | 12 | 2020 | 1155 | 0.860 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 533 | 0.820 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 311 | 0.780 |
Why?
|
| Physicians, Primary Care | 1 | 2023 | 64 | 0.760 |
Why?
|
| Safety-net Providers | 4 | 2020 | 55 | 0.750 |
Why?
|
| United States | 20 | 2023 | 3891 | 0.710 |
Why?
|
| Time Factors | 8 | 2020 | 1044 | 0.630 |
Why?
|
| Telephone | 5 | 2019 | 150 | 0.630 |
Why?
|
| Healthcare Disparities | 5 | 2021 | 205 | 0.610 |
Why?
|
| Randomized Controlled Trials as Topic | 10 | 2022 | 316 | 0.610 |
Why?
|
| Comparative Effectiveness Research | 3 | 2020 | 63 | 0.610 |
Why?
|
| Pragmatic Clinical Trials as Topic | 5 | 2022 | 61 | 0.600 |
Why?
|
| Health Personnel | 2 | 2022 | 126 | 0.570 |
Why?
|
| Disease Management | 4 | 2020 | 127 | 0.570 |
Why?
|
| Cost-Benefit Analysis | 7 | 2023 | 226 | 0.550 |
Why?
|
| Adult | 21 | 2023 | 7529 | 0.550 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 366 | 0.540 |
Why?
|
| Case Management | 2 | 2015 | 29 | 0.530 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 395 | 0.530 |
Why?
|
| Patient Education as Topic | 4 | 2020 | 193 | 0.530 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 198 | 0.530 |
Why?
|
| Motor Activity | 3 | 2015 | 208 | 0.520 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 200 | 0.520 |
Why?
|
| Evidence-Based Practice | 2 | 2013 | 55 | 0.510 |
Why?
|
| Community Health Centers | 2 | 2020 | 64 | 0.500 |
Why?
|
| Weight Loss | 4 | 2022 | 295 | 0.500 |
Why?
|
| Specimen Handling | 1 | 2016 | 24 | 0.500 |
Why?
|
| Hispanic Americans | 2 | 2014 | 378 | 0.480 |
Why?
|
| Patient Participation | 1 | 2016 | 123 | 0.480 |
Why?
|
| Lipids | 1 | 2015 | 69 | 0.470 |
Why?
|
| Program Development | 3 | 2020 | 64 | 0.470 |
Why?
|
| Smartphone | 1 | 2014 | 10 | 0.460 |
Why?
|
| Mobile Applications | 1 | 2014 | 14 | 0.460 |
Why?
|
| Patient Navigation | 1 | 2014 | 19 | 0.450 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1287 | 0.450 |
Why?
|
| Chronic Disease | 2 | 2015 | 405 | 0.450 |
Why?
|
| Negotiating | 1 | 2014 | 4 | 0.440 |
Why?
|
| Health Care Reform | 1 | 2014 | 20 | 0.440 |
Why?
|
| Self Efficacy | 1 | 2014 | 67 | 0.440 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 20 | 0.440 |
Why?
|
| Preventive Health Services | 2 | 2014 | 152 | 0.430 |
Why?
|
| Health Literacy | 1 | 2014 | 38 | 0.420 |
Why?
|
| Family Practice | 1 | 2013 | 41 | 0.420 |
Why?
|
| Health Services Accessibility | 3 | 2021 | 274 | 0.410 |
Why?
|
| Advisory Committees | 1 | 2014 | 112 | 0.400 |
Why?
|
| Qualitative Research | 6 | 2020 | 262 | 0.390 |
Why?
|
| Anxiety | 1 | 2013 | 154 | 0.390 |
Why?
|
| Population Surveillance | 1 | 2014 | 254 | 0.390 |
Why?
|
| Cholesterol | 1 | 2012 | 82 | 0.380 |
Why?
|
| Nurses | 1 | 2011 | 34 | 0.370 |
Why?
|
| Risk Factors | 8 | 2023 | 3255 | 0.360 |
Why?
|
| Treatment Outcome | 6 | 2015 | 1170 | 0.360 |
Why?
|
| Office Visits | 1 | 2011 | 74 | 0.360 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2023 | 131 | 0.350 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 142 | 0.350 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 134 | 0.350 |
Why?
|
| Obesity | 3 | 2011 | 814 | 0.340 |
Why?
|
| Patient Care | 2 | 2008 | 30 | 0.340 |
Why?
|
| Interviews as Topic | 5 | 2017 | 304 | 0.340 |
Why?
|
| Sigmoidoscopy | 4 | 2014 | 65 | 0.320 |
Why?
|
| Self Care | 3 | 2022 | 145 | 0.310 |
Why?
|
| Quality Improvement | 3 | 2022 | 190 | 0.300 |
Why?
|
| Remote Consultation | 1 | 2008 | 9 | 0.300 |
Why?
|
| Body Mass Index | 1 | 2012 | 937 | 0.280 |
Why?
|
| Public Health | 4 | 2020 | 82 | 0.280 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 70 | 0.270 |
Why?
|
| Age Factors | 4 | 2015 | 884 | 0.270 |
Why?
|
| Sex Factors | 3 | 2015 | 607 | 0.260 |
Why?
|
| Socioeconomic Factors | 3 | 2021 | 609 | 0.260 |
Why?
|
| Quality of Life | 2 | 2015 | 505 | 0.240 |
Why?
|
| Oregon | 3 | 2020 | 172 | 0.230 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 677 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2016 | 211 | 0.230 |
Why?
|
| Program Evaluation | 4 | 2020 | 215 | 0.220 |
Why?
|
| Mammography | 2 | 2016 | 168 | 0.220 |
Why?
|
| Patient Preference | 2 | 2014 | 49 | 0.210 |
Why?
|
| Health Promotion | 2 | 2016 | 278 | 0.210 |
Why?
|
| Medication Adherence | 2 | 2016 | 239 | 0.210 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2013 | 537 | 0.200 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 13 | 0.200 |
Why?
|
| Exercise | 1 | 2007 | 513 | 0.190 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 977 | 0.190 |
Why?
|
| Single-Blind Method | 2 | 2014 | 40 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2003 | 140 | 0.190 |
Why?
|
| Pandemics | 2 | 2021 | 285 | 0.180 |
Why?
|
| Electronic Mail | 3 | 2013 | 51 | 0.180 |
Why?
|
| Health Maintenance Organizations | 1 | 2003 | 408 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 20 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 120 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2017 | 26 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 37 | 0.170 |
Why?
|
| Cross Infection | 1 | 2020 | 25 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 53 | 0.170 |
Why?
|
| Comorbidity | 3 | 2021 | 564 | 0.170 |
Why?
|
| Preventive Medicine | 2 | 2013 | 22 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 84 | 0.170 |
Why?
|
| Prognosis | 3 | 2020 | 604 | 0.170 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 66 | 0.170 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 342 | 0.170 |
Why?
|
| Life Style | 3 | 2017 | 316 | 0.160 |
Why?
|
| Medical Informatics | 2 | 2017 | 35 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 1942 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.160 |
Why?
|
| Financial Support | 1 | 2019 | 5 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2023 | 2428 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.160 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2016 | 9 | 0.160 |
Why?
|
| Demography | 1 | 2019 | 96 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2020 | 211 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2019 | 148 | 0.150 |
Why?
|
| Infertility, Female | 2 | 1988 | 11 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 151 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2017 | 15 | 0.140 |
Why?
|
| Awareness | 1 | 2017 | 17 | 0.140 |
Why?
|
| Culturally Competent Care | 1 | 2017 | 11 | 0.140 |
Why?
|
| Leadership | 1 | 2017 | 35 | 0.140 |
Why?
|
| Medically Uninsured | 2 | 2014 | 41 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2021 | 1079 | 0.140 |
Why?
|
| Neoplasms | 1 | 2022 | 448 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2017 | 51 | 0.140 |
Why?
|
| Classification | 1 | 2016 | 2 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 2 | 2015 | 32 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2017 | 75 | 0.130 |
Why?
|
| Workflow | 1 | 2016 | 11 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 174 | 0.130 |
Why?
|
| Focus Groups | 1 | 2016 | 144 | 0.130 |
Why?
|
| Aftercare | 1 | 2016 | 48 | 0.120 |
Why?
|
| Communication | 2 | 2014 | 181 | 0.120 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 22 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2015 | 3 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 114 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2015 | 86 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2014 | 11 | 0.110 |
Why?
|
| Inservice Training | 1 | 2014 | 14 | 0.110 |
Why?
|
| Comprehension | 1 | 2014 | 18 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 38 | 0.110 |
Why?
|
| Financing, Government | 1 | 2014 | 26 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 45 | 0.110 |
Why?
|
| Logistic Models | 2 | 2014 | 884 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2014 | 46 | 0.110 |
Why?
|
| Language | 1 | 2014 | 48 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 14 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 41 | 0.110 |
Why?
|
| Utilization Review | 1 | 2013 | 44 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2014 | 103 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 165 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 68 | 0.100 |
Why?
|
| Community Health Services | 1 | 2013 | 79 | 0.100 |
Why?
|
| Directive Counseling | 1 | 2012 | 23 | 0.100 |
Why?
|
| Papillomaviridae | 2 | 2023 | 61 | 0.100 |
Why?
|
| Health Services Research | 1 | 2013 | 212 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 355 | 0.100 |
Why?
|
| Risk | 2 | 2011 | 498 | 0.100 |
Why?
|
| California | 2 | 2017 | 2317 | 0.100 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 22 | 0.100 |
Why?
|
| Treatment Refusal | 1 | 2012 | 30 | 0.100 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2011 | 4 | 0.090 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2011 | 6 | 0.090 |
Why?
|
| Nurse's Role | 1 | 2011 | 7 | 0.090 |
Why?
|
| Ovulation | 2 | 1988 | 5 | 0.090 |
Why?
|
| Diet | 1 | 2014 | 356 | 0.090 |
Why?
|
| Models, Organizational | 1 | 2011 | 54 | 0.090 |
Why?
|
| Forecasting | 1 | 2011 | 69 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 280 | 0.090 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2011 | 98 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 169 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2011 | 85 | 0.090 |
Why?
|
| Nursing Care | 1 | 2010 | 4 | 0.090 |
Why?
|
| Incidence | 3 | 2021 | 1266 | 0.090 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 10 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 27 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 367 | 0.090 |
Why?
|
| Quality Control | 1 | 2010 | 42 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 210 | 0.090 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 12 | 0.080 |
Why?
|
| Educational Status | 1 | 2011 | 179 | 0.080 |
Why?
|
| Social Class | 1 | 2011 | 117 | 0.080 |
Why?
|
| Continental Population Groups | 1 | 2012 | 289 | 0.080 |
Why?
|
| Northwestern United States | 2 | 2016 | 53 | 0.080 |
Why?
|
| Health Behavior | 1 | 2012 | 345 | 0.080 |
Why?
|
| Data Collection | 1 | 2010 | 240 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 439 | 0.080 |
Why?
|
| Adolescent | 4 | 2020 | 3533 | 0.070 |
Why?
|
| Registries | 1 | 2010 | 460 | 0.070 |
Why?
|
| African Americans | 1 | 2011 | 443 | 0.070 |
Why?
|
| Process Assessment (Health Care) | 1 | 2007 | 23 | 0.070 |
Why?
|
| Body Weight | 1 | 1988 | 203 | 0.070 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 104 | 0.070 |
Why?
|
| Physical Exertion | 1 | 1986 | 15 | 0.070 |
Why?
|
| Group Practice, Prepaid | 1 | 2006 | 6 | 0.060 |
Why?
|
| Chlamydia trachomatis | 1 | 2006 | 7 | 0.060 |
Why?
|
| Women's Health Services | 1 | 2006 | 16 | 0.060 |
Why?
|
| Chlamydia Infections | 1 | 2006 | 23 | 0.060 |
Why?
|
| Quality of Health Care | 2 | 2014 | 279 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2006 | 63 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2526 | 0.060 |
Why?
|
| Breast Self-Examination | 1 | 2003 | 4 | 0.050 |
Why?
|
| Idaho | 2 | 2013 | 24 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2003 | 16 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2022 | 22 | 0.050 |
Why?
|
| Suburban Health Services | 1 | 2002 | 1 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2002 | 37 | 0.050 |
Why?
|
| Emotions | 1 | 2021 | 34 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 455 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2021 | 14 | 0.050 |
Why?
|
| Health Surveys | 1 | 2002 | 250 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2021 | 18 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2021 | 68 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 14 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 16 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 13 | 0.040 |
Why?
|
| Counseling | 1 | 2002 | 173 | 0.040 |
Why?
|
| Patient Safety | 1 | 2020 | 38 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2020 | 12 | 0.040 |
Why?
|
| Immunochemistry | 1 | 2020 | 18 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 35 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 2473 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 295 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 148 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 175 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 11 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 171 | 0.040 |
Why?
|
| Research Report | 1 | 2017 | 23 | 0.030 |
Why?
|
| Confidentiality | 1 | 2017 | 25 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 74 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1100 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 120 | 0.030 |
Why?
|
| Blood Pressure Monitors | 1 | 2016 | 2 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1229 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 172 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 805 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2015 | 41 | 0.030 |
Why?
|
| Text Messaging | 1 | 2015 | 34 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 185 | 0.030 |
Why?
|
| Consensus | 1 | 2014 | 40 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 11 | 0.030 |
Why?
|
| Curriculum | 1 | 2014 | 34 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1287 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2013 | 9 | 0.030 |
Why?
|
| Editorial Policies | 1 | 2013 | 5 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2013 | 25 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 27 | 0.030 |
Why?
|
| Minority Groups | 1 | 2014 | 103 | 0.030 |
Why?
|
| Role Playing | 1 | 2012 | 1 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2012 | 218 | 0.020 |
Why?
|
| Oligomenorrhea | 1 | 1988 | 1 | 0.020 |
Why?
|
| Income | 1 | 1986 | 87 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2006 | 152 | 0.010 |
Why?
|